Navigation Links
Leading Children's Hospital Utilizes MEDai's Solutions to Deliver Outstanding Care
Date:10/18/2007

IV Center, and pediatric abuse and violence intervention, cardiac, cystic fibrosis/pulmonary, endocrine, gastrointestinal, rehabilitation, renal, rheumatology and spina bifida centers.

About MEDai

MEDai, Inc. is a leading health information company offering award-winning business intelligence solutions for the improvement of healthcare delivery. Utilizing cutting-edge predictive analytics, payors and care management organizations are able to forecast patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit http://www.medai.com.

For More Information Contact:

Lizzy Feliciano, MBA

Manager

Marketing & Communications

MEDai, Inc.

(800) 446-3324


'/>"/>
SOURCE MEDai, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Misleading anti-malarial drug
3. Misleading Advertisements for Prescription Drugs
4. The Effects Of Smoking Misleading
5. Antidepressant Medication Leading To Suicidal Thoughts
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Historic trial for tuberculosis launched together by leading drug companies
8. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
9. Down’s Syndrome Is The Leading Birth Defect In the U
10. Exposure to Grating, Noise, Music Can Cause Tumors Leading To Deafness
11. Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...GH, N.C., Dec. 4 The de...ar disorder who died on April 29 in a North Carol... on medication -- while, nearby, hospital employee...focused attention on the crisis in North Carolina,...eventable death of Steven Sabock -- which made hea...
(Date:12/4/2008)...LAND, Dec. 4 Of the estimated 25 t...yndrome (IBS), a significant number avoid,seeing ...g during the holiday,season because of their dige...dictable digestive symptoms often make road trips ...popular holiday meals nearly impossible. , ...
(Date:12/4/2008)...for Increased Giving Prevails: Colorado Trails the... Peaks , , DENVER, Dec. 4 M...give the same amount or give more to charitable ca...Generous Colorado: Why Donors Give ," the first st...ects data from surveys conducted October 2008. Wit...
(Date:12/4/2008)...ORK, Dec. 4 VirtualHealt...nnounced that the Company is presently,featured i...m . Mr. Scott Hare,CEO for VirtualHealth Techno...,encryption and security software as it relates to...terview. Mr. Hare also discusses the short term s...
Breaking Medicine News(10 mins):Health News:Tragedy Focuses Spotlight on Crisis in North Carolina Mental Health System 2Health News:There's No Place Like the Bathroom During the Holidays 2Health News:There's No Place Like the Bathroom During the Holidays 3Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 2Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 3Health News:Economy Doesn't Dampen Colorado's Giving Spirit According to Statewide Giving and Volunteering Study 4Health News:VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview 2Health News:VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview 3
...victim to heart disease increased if the infant di... external factors. "The risk of premature cardiova...l syndrome, //especially when the fetus is adverse... of the study. "We believe the maternal placental ...
...itioned Hollywood movie executives to add anti-smo...ses which shows stars smoking. According to contac...rran initiated the petition after noting scientifi... 'Young people who watch smoking in movies are mor...
...claim of having produced and purified stem cells f... not have many takers in the British medical frate...ere have called // on Indian authorities to impose...India that make extravagant claims about the use o...
...y licensed therapists do is no laughing matter. T...! The first 49 laughing therapists recently passed...e patients laugh to improve their immune system, a...s, said Kazue Takayanagi, assistant professor and ...
Other Medicine News:Health News:British Scientists Doubt Delhi Doctor’s Stem Cell Claim 2Health News:Are You Ill? Have A Hard Laugh! 2
(Date:12/4/2008)...4 Velos, Inc., the recognized lead...ment information systems, today announced that it ...nsas Medical Center (KU Medical Center). KU Medic...ensive, system-wide roll-out that supports the reg...formation needs of the institution,s clinical rese...
(Date:12/3/2008)... Roche today announced that the U.S...further guidance on the requirements for the Biolo...ilizumab), the first interleukin-6 (IL-6) receptor...eatment of adult patients with moderately to sever...As a result of the FDA,s evolving Risk Evaluation ...
(Date:12/3/2008)...t alleviates long-term anemia and organ damage in ... , MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewsw...ive gene into mouse blood cells, scientists at St.... sickle cell disease pathology. In their studies, ... essentially no difference from normal mice. Altho...
(Date:12/3/2008)...c. 3 Wyeth Pharmaceutica... today that it has submitted a,marketing authoriz...Agency,(EMEA) for approval to market its investig...(PCV13) for infants and young children. Wyeth is ...ococcal disease (PD) caused by the 13,serotypes i...
Breaking Medicine Technology:University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Discovery of cell linked to learning and memory 19314 1Symposium focuses on curable cancer that affects young men 19310 1Symposium focuses on curable cancer that affects young men 19310 2Stop Obesity Alliance Chair Dr Richard H Carmona National Opinion Research Center Reveal Findings of Survey Showing Employer Concern About Health 19306 1Stop Obesity Alliance Chair Dr Richard H Carmona National Opinion Research Center Reveal Findings of Survey Showing Employer Concern About Health 19306 2Stop Obesity Alliance Chair Dr Richard H Carmona National Opinion Research Center Reveal Findings of Survey Showing Employer Concern About Health 19306 3Tianyin Pharmaceutical Co Inc to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday May 15 2008 at 9 3A00 a m EDT 19302 1Tianyin Pharmaceutical Co Inc to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday May 15 2008 at 9 3A00 a m EDT 19302 2
...(BUSINESS WIRE)--Jun 26, 2007 - Sirtris,Pharmaceut...mpany,focused on discovering and developing small ...ed today that activation of SIRT1, a,member of the...gainst neurodegenerative diseases such as Alzheime...nimal models. These findings,appear in an article ...
...ne 26, 2007 /PRNewswire-FirstCall/ -- Micromet,In...evelopment of,novel, proprietary antibody-based pr...eases, announced that a study published recently,i...ces (1) supports,the findings of several other stu...et for Micromet,s product candidates adecatumumab,...
Other Medicine Technology:Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 2Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 3Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 2Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 3Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 4
The Minilyser offers a combination of three well proven instruments for fully automated processing of microplates. The Minilyser is the optimal fully automated ELISA and EIA equipment for laboratorie
...esis RMP is ideal for hospital laboratories, blood...armaceutical laboratories. It fully automates the ...nd EIA assays from different manufacturers. The Ge...p to 600'000 tests, using 4 needles, 8 needles or ...
...ection of Anti-Nuclear Antibodies (ANAs) has long ...c rheumatic diseases. The antigens used in their d...human or animal nuclei, this has led to them being...ost commonly measured ENA specifications are anti-...
IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULIT
Medicine Products: